Aimmune治疗

AIMT NASDAQ
20.23
-0.31
-1.51%
交易中 15:07 06/18 EDT
开盘
20.67
昨收
20.54
最高
20.84
最低
20.20
成交量
20.86万
成交均量(3M)
48.59万
52周最高
36.12
52周最低
19.25
换手率
0.33%
市值
12.64亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aimmune治疗 AIMT股票价格,Aimmune治疗股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. The Company's therapeutic approach, which it refers to as Characterized Oral Desensitization Immunotherapy (CODIT), is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols and support services. The Company's lead CODIT product candidate, AR101, is an investigational biologic for the treatment of patients with peanut allergy. The Company has initiated Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE), its Phase III registration trial of AR101. The Company is in the process of evaluating additional delivery forms for AR101 for the maintenance phase.
展开 >

最近浏览

名称
价格
涨跌幅